PrintyMed
PrivateLast Round
Grant
Apr 28, 2026
Total Funding Raised
$1.62M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
PrintyMed is a biotechnology company that develops biomimetic spider silk materials for use in regenerative medicine and 3D-printed artificial organs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials, Medical Devices, Fashion & Beauty, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PrintyMed Comparables
Compare PrintyMed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Spiber Technologies AB | 84% | |
| Seevix Material Sciences | 80% | |
| Cellbox Labs | 74% | |
PrintyMed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 28, 2026 | ||||
| Grant | Mar 5, 2026 | ||||
| Accelerator | Sep 23, 2025 | ||||
| Grant | Oct 8, 2024 | ||||
| Grant | Dec 11, 2023 | ||||
Pre Seed | Aug 28, 2023 |
PrintyMed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Confluence | Accelerator |
| Investment and Development Agency of Latvia | Grant, Accelerator |
| Health Founders | Pre Seed |
| Women TechEU | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 5, 2026
$86K grant received from Women TechEU
- Sep 23, 2025
$6K round from Confluence, Helve, and Investment and Development Agency of Latvia.
PrintyMed Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PrintyMed's valuation, stock price, and market status.